https://www.selleckchem.com/products/ABT-888.html
treatment, or 30-day mortality, reflecting the maintenance of the quality of care for digestive cancer patients. The impact of SARS-CoV-2 infection on the liver and the possibility of chronic liver disease (CLD) as a risk factor for COVID-19 severity is not fully understood. Our goal was to describe clinical outcomes of COVID-19 inpatients regarding the presence of abnormal liver tests and CLD. A retrospective analysis of patients with SARS-CoV-2 infection, hospitalized in a tertiary center in Portugal, was performed. Studied outcomes w
Like
Comment
Share
